دورية أكاديمية
P134 - Topic: AS08-Treatment/AS08f-Clinical trials – Phase II-III: SELECT-MDS-1 TRIAL IN PROGRESS: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF TAMIBAROTENE/AZACITIDINE VS PLACEBO/AZACITIDINE IN NEWLY DIAGNOSED (ND) ADULT PATIENTS SELECTED FOR RARA-POSITIVE HR-MDS
العنوان: | P134 - Topic: AS08-Treatment/AS08f-Clinical trials – Phase II-III: SELECT-MDS-1 TRIAL IN PROGRESS: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF TAMIBAROTENE/AZACITIDINE VS PLACEBO/AZACITIDINE IN NEWLY DIAGNOSED (ND) ADULT PATIENTS SELECTED FOR RARA-POSITIVE HR-MDS |
---|---|
المؤلفون: | Dezern, A., Fenaux, P., Deeren, D., Campelo, M., Lübbert, M., Krishnamurthy, P., Nagy, Z., Basak, G., Jonasova, A., Geissler, K., Ofran, Y., Klimek, V., Volkert, A., Chisholm, J., Hu, B., Hodgson, G., Roth, D.A., Kelly, M., Marconi, G. |
المصدر: | In Leukemia Research May 2023 128 Supplement |
قاعدة البيانات: | ScienceDirect |
كن أول من يترك تعليقا!